Glomerular filtration rate
- 16 November 2006
- Vol. 333 (7577) , 1030-1031
- https://doi.org/10.1136/bmj.39030.594259.be
Abstract
Low glomerular filtration rate predicts cardiovascular disease, end stage renal disease (a requirement for dialysis or transplantation), and death.1 In a population based study reported in this week's issue, Hallan and colleagues describe the yield of different screening strategies aimed at identifying people with low glomerular filtration rates.1 The guidelines of the United States kidney disease outcomes quality initiative define chronic kidney disease as glomerular filtration rate persistently lower than 60 ml/min/1.73m2, persistent urine abnormalities, or clinically relevant anatomical abnormalities, and they recommend measuring serum creatinine to determine estimated glomerular filtration rate in high risk groups.2 The Kidney Disease Improving Global Outcomes Group (an international organisation that seeks to improve care and outcomes for people with kidney disease) and draft UK guidelines endorse the classification but do not, at present, look at screening.3 4 All screening programmes cause physical, psychological, and social harm through the screening test itself, and through the investigation and treatment of abnormal results. No trials to show whether the benefits of screening for low glomerular filtration rate outweigh the harms have been conducted. So how …Keywords
This publication has 10 references indexed in Scilit:
- Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health surveyBMJ, 2006
- Low protein diets for chronic kidney disease in non diabetic adultsPublished by Wiley ,2006
- Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)Kidney International, 2005
- Renal Outcomes in High-Risk Hypertensive Patients Treated With an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker vs a DiureticArchives of internal medicine (1960), 2005
- Unreferred chronic kidney disease: a longitudinal studyAmerican Journal of Kidney Diseases, 2004
- National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and StratificationAnnals of Internal Medicine, 2003
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyNew England Journal of Medicine, 2001
- Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal DiseaseAnnals of Internal Medicine, 2001
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Effects of labelling on income, work and social function among hypertensive employeesJournal of Chronic Diseases, 1984